Aromatase inhibitors

M L71 Pill - pink round, 6mm

Pill with imprint M L71 is Pink, Round and has been identified as Letrozole 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-M L71-2.5 mg-Pink-Round
Letrozole (Letrozole [ let-roe-zol ])-M L71-2.5 mg-Pink-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: M L71
Strength: 2.5 mg
Color: Pink
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-2071 (Discontinued)
Inactive Ingredients: Silicon dioxide, D&C Red No. 27, FD&C Blue No. 2, FD&C Red No. 40, Hypromelloses, Lactose anhydrous, Magnesium stearate, Microcrystalline cellulose, Polydextrose, Polyethylene glycol, Corn starch, Sodium lauryl sulfate, Sodium starch glycolate type A potato, Titanium dioxide, Triacetin,
Latest News
Related Drugs